A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]Subasumstat in Patients With Advanced or Metastatic Solid Tumors
Latest Information Update: 08 Aug 2024
At a glance
- Drugs Subasumstat (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Takeda
Most Recent Events
- 02 Aug 2024 According to ClinicalTrials.gov record, this trial was terminated due to Business reasons
- 02 Aug 2024 Status changed from recruiting to discontinued.
- 08 Dec 2023 Status changed from not yet recruiting to recruiting.